Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease

Authors: Matthew J. Walters, Yu Wang, Nicholas Lai, Trageen Baumgart, Bin Zhao, Daniel J. Dairaghi, Pirow Bekker, Linda Ertl, Mark E.T. Penfold, Juan C. Jaén, Satish Keshav, Emily Wendt, Andrew M. K. Pennell, S Ungashe, Zheng Wei, John Joseph Wright, Thomas J. Schall - Journal of Pharmacology and Experimental Therapeutics 2010 cited by 159